You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1689487 |
---|---|
Category | Small Molecules |
Description | SARS-CoV-2-IN-14 |
CAS Number | 22203-98-1 |
Purity | 98% |
MW | 282.12 |
SMILES | Oc1ccc(Cl)cc1C(=O)Nc1cccc(Cl)c1 |
Formula | C13H9Cl2NO2 |
Biological Activity | SARS-CoV-2-IN-14 is a niclosamide analogue. Niclosamide, a widely-used anthelmintic drug, inhibits SARS-CoV-2 virus entry through TMEM16F inhibition and replication through autophagy induction. SARS-CoV-2-IN-14 shows potent inhibition against SARS-CoV-2 with an IC 50 of 0.39 μM which is comparable efficacy to niclosamide. On the other hand, SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally [1]. |
Storage | -20°C |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
Filter by Rating